MMWR News Synopsis
Friday, January 3, 2020
- State-Specific Prevalence and Characteristics of Frequent Mental Distress and History of Depression Diagnosis Among Adults with Arthritis — United States, 2017
- Description of Eschar-Associated Rickettsial Diseases Using Passive Surveillance Data — United States, 2010–2016
- Characteristics of Patients Experiencing Rehospitalization or Death After Hospital Discharge in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, 2019
- Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge — United States, December 2019
- QuickStats
- Recommendations and Reports
State-Specific Prevalence and Characteristics of Frequent Mental Distress and History of Depression Diagnosis Among Adults with Arthritis — United States, 2017
CDC Media Relations
404-639-3286
In the U.S., about 1 in 3 adults with arthritis report ever having depression and 1 in 5 report frequent mental distress with the highest prevalence of these conditions found in women, lesbian/gay/bisexual adults, and residents of states in the Appalachian/Southern region. In 2017, frequent mental distress and depression were commonly reported by adults with arthritis in all states, especially in Appalachian/Southern region states. Additionally, mental distress among those with arthritis was reported more by women and lesbian/gay/bisexual adults. All adults with arthritis might benefit from regular mental health screening by their healthcare team, by referral to mental health services, and by participation in evidence-based interventions such as physical activity and self-management education programs that have proven benefits including pain reduction and improved mental health.
Description of Eschar-Associated Rickettsial Diseases Using Passive Surveillance Data — United States, 2010–2016
CDC Media Relations
404-639-3286
Eschars are an underused clinical clue in rickettsial disease surveillance that can help tease out less-severe rickettsioses from potentially deadly Rocky Mountain spotted fever. Eschars are scabbed lesions that appear when certain rickettsial bacteria pass from a tick or mite into the skin. Eschars are a common clinical clue to less-severe rickettsial diseases in the United States, including Rickettsia parkeri rickettsiosis, but are not associated with deadly Rocky Mountain spotted fever (RMSF). Analysis shows that eschar-associated infections represent only 1% of all tickborne rickettsial diseases reported from 2010–2016 – but information was missing in 81% of forms, limiting the usefulness of such data. Eschar-associated illnesses were less severe and most cases appeared in the South (consistent with areas where ticks spreading eschar-causing bacteria are present). Rates of spotted fever rickettsiosis are rising and increased reporting of eschars will help differentiate the burden of less-severe rickettsioses from RMSF.
Characteristics of Patients Experiencing Rehospitalization or Death After Hospital Discharge in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, 2019
CDC Media Relations
404-639-3286
Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge — United States, December 2019
CDC Media Relations
404-639-3286
Health care settings can use CDC’s recommendations to assess and identify opportunities to build, maintain, or enhance their delivery of STD care. Approximately 20 million new cases of sexually transmitted diseases (STDs) occur every year in the United States, and the rates for most STDs have increased in recent years. Timely diagnosis and treatment are critical to reduce STD transmission. A new CDC report, Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services (STD QCS), highlights the services healthcare settings can offer to provide the highest-quality STD clinical care for patients, including on-site testing and treatment and other services that should be available on the same day of the patient visit. Healthcare settings can use the recommendations to assess which STD care services they should offer and identify opportunities to build, maintain or enhance their delivery of STD care. STD QCS complements CDC’s 2015 Sexually Transmitted Diseases Treatment Guidelines, which provides guidance on the clinical management of patients with or at risk for STDs in the United States.
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CDC works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.
